Lung cancer is the leading cause of cancer mortality for both men and women in the US. Current cytotoxic chemotherapy for lung cancer lacks specificity and efficacy, which provides an impetus to develop targeted therapies to achieve greater efficacy with fewer side effects. The long-term goal of this application is to develop polymeric micelles as an enabling nanomedicine platform to achieve targeted therapy for lung cancer. Hydrophobic drugs will be loaded inside the micelle cores to overcome limitations of low water solubility and poor pharmacokinetics. Recently, we demonstrated that micelles encoding surface functionalized cyclic Arg-Gly-Asp (cRGD) peptide have dramatically increased (>30 fold) uptake in alpha(v)beta(3) integrin-overexpressing tumor endothelial cells and subsequently resulted in efficient targeting to solid tumors in vivo. In this application, we will apply the micelle technology to incorporate a novel class of lung cancer targeting peptides identified from phage screening for specific drug targeting to lung cancer cells. The isolated peptides have demonstrated remarkable binding affinities (

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA122994-01A1
Application #
7260606
Study Section
Gene and Drug Delivery Systems Study Section (GDD)
Program Officer
Fu, Yali
Project Start
2007-05-01
Project End
2011-02-28
Budget Start
2007-05-01
Budget End
2008-02-29
Support Year
1
Fiscal Year
2007
Total Cost
$268,470
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Pharmacology
Type
Schools of Medicine
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Huang, Gang; Chen, Huabing; Dong, Ying et al. (2013) Superparamagnetic iron oxide nanoparticles: amplifying ROS stress to improve anticancer drug efficacy. Theranostics 3:116-26
Yu, Haijun; Zou, Yonglong; Wang, Yiguang et al. (2011) Overcoming endosomal barrier by amphotericin B-loaded dual pH-responsive PDMA-b-PDPA micelleplexes for siRNA delivery. ACS Nano 5:9246-55
Ding, Huiying; Mora, Ruben; Gao, Jinming et al. (2011) Characterization and optimization of mTHPP nanoparticles for photodynamic therapy of head and neck cancer. Otolaryngol Head Neck Surg 145:612-7
Ding, Huiying; Yu, Haijun; Dong, Ying et al. (2011) Photoactivation switch from type II to type I reactions by electron-rich micelles for improved photodynamic therapy of cancer cells under hypoxia. J Control Release 156:276-80
Ding, Huiying; Sumer, Baran D; Kessinger, Chase W et al. (2011) Nanoscopic micelle delivery improves the photophysical properties and efficacy of photodynamic therapy of protoporphyrin IX. J Control Release 151:271-7
Guthi, Jagadeesh Setti; Yang, Su-Geun; Huang, Gang et al. (2010) MRI-visible micellar nanomedicine for targeted drug delivery to lung cancer cells. Mol Pharm 7:32-40
Blanco, Elvin; Bey, Erik A; Khemtong, Chalermchai et al. (2010) Beta-lapachone micellar nanotherapeutics for non-small cell lung cancer therapy. Cancer Res 70:3896-904
Blanco, Elvin; Kessinger, Chase W; Sumer, Baran D et al. (2009) Multifunctional micellar nanomedicine for cancer therapy. Exp Biol Med (Maywood) 234:123-31